Your browser doesn't support javascript.
loading
Are patients with bipolar disorder and comorbid attention-deficit hyperactivity disorder more neurocognitively impaired?
Torres, Imma; Sole, Brisa; Corrales, Montse; Jiménez, Esther; Rotger, Sofia; Serra-Pla, Juan Francisco; Forcada, Irene; Richarte, Vanesa; Mora, Ester; Jacas, Carlos; Gómez, Nuria; Mur, Maria; Colom, Francesc; Vieta, Eduard; Casas, Miquel; Martinez-Aran, Anabel; Goikolea, Jose M; Ramos-Quiroga, Josep A.
Afiliação
  • Torres I; Bipolar Disorder Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Sole B; Bipolar Disorder Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Corrales M; ADHD Program, Department of Psychiatry, Hospital Universitari Vall d'Hebron, CIBERSAM, Barcelona, Catalonia, Spain.
  • Jiménez E; Bipolar Disorder Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Rotger S; Psychiatric Service, Santa Maria University Hospital, IRB Lleida (Biomedicine Research, Institute), University of Lleida, Lleida, Catalonia, Spain.
  • Serra-Pla JF; ADHD Program, Department of Psychiatry, Hospital Universitari Vall d'Hebron, CIBERSAM, Barcelona, Catalonia, Spain.
  • Forcada I; Psychiatric Service, Santa Maria University Hospital, IRB Lleida (Biomedicine Research, Institute), University of Lleida, Lleida, Catalonia, Spain.
  • Richarte V; ADHD Program, Department of Psychiatry, Hospital Universitari Vall d'Hebron, CIBERSAM, Barcelona, Catalonia, Spain.
  • Mora E; Children and Adolescents Center of Mental Health, Sant Joan de Déu Lleida, University of Lleida, IRB Lleida (Biomedicine Research Institute), Lleida, Catalonia, Spain.
  • Jacas C; ADHD Program, Department of Psychiatry, Hospital Universitari Vall d'Hebron, CIBERSAM, Barcelona, Catalonia, Spain.
  • Gómez N; ADHD Program, Department of Psychiatry, Hospital Universitari Vall d'Hebron, CIBERSAM, Barcelona, Catalonia, Spain.
  • Mur M; Psychiatric Service, Santa Maria University Hospital, IRB Lleida (Biomedicine Research, Institute), University of Lleida, Lleida, Catalonia, Spain.
  • Colom F; Mental Health Program, Hospital del Mar Medical Research Institute (IMIM), CIBERSAM, Barcelona, Catalonia, Spain.
  • Vieta E; Bipolar Disorder Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Casas M; ADHD Program, Department of Psychiatry, Hospital Universitari Vall d'Hebron, CIBERSAM, Barcelona, Catalonia, Spain.
  • Martinez-Aran A; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
  • Goikolea JM; Bipolar Disorder Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Ramos-Quiroga JA; Bipolar Disorder Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
Bipolar Disord ; 19(8): 637-650, 2017 12.
Article em En | MEDLINE | ID: mdl-28941032
ABSTRACT

OBJECTIVE:

Research on neurocognitive impairment in adult patients with comorbid bipolar disorder (BD) and attention-deficit hyperactivity disorder (ADHD) is very scarce. This study assessed the neurocognitive profile of a comorbid group (BD+ADHD) compared with that of pure BD (pBD) group, pure ADHD (pADHD) group and healthy controls (HCs).

METHODS:

This was a three-site study comprising 229

subjects:

70 patients with pBD, 23 with BD+ADHD, 50 with pADHD, and 86 HCs. All patients with BD had been euthymic for at least 6 months. Neuropsychological performance was assessed using a comprehensive neurocognitive battery.

RESULTS:

Our results showed that all the clinical groups had poorer performance than the HCs in all the neurocognitive domains except for executive functions. No significant differences were observed between the pBD and BD+ADHD groups in any of the cognitive domains, with these two groups showing greater impairment than the pADHD group in executive functions and visual memory.

CONCLUSIONS:

Our results, although preliminary, suggest that the BD+ADHD group showed the same neurocognitive profile as pBD patients, most likely reflecting the same neurobiological basis. On the other hand, the pADHD group showed a more selective moderate impairment in attention.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Transtorno Bipolar / Transtornos Neurocognitivos Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Transtorno Bipolar / Transtornos Neurocognitivos Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article